These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19744594)

  • 21. The incidence and predictors of contrast-induced nephropathy in adequately hydrated elderly patients with impaired renal function.
    Park KW; Koo BK; Kim HL; Kim YS; Jo SH; Lee HY; Kang HJ; Cho YS; Chung WY; Yeon TJ; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB
    Nephrol Dial Transplant; 2007 Jun; 22(6):1794-5. PubMed ID: 17324945
    [No Abstract]   [Full Text] [Related]  

  • 22. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
    Morcos SK
    Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-induced acute kidney injury: how should at-risk patients be identified and managed?
    Laville M; Juillard L
    J Nephrol; 2010; 23(4):387-98. PubMed ID: 20349411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and risk factors of contrast-induced nephropathy after contrast procedures in a Nigerian tertiary centre.
    Okoye O; Ojogwu L; Unuigbe E; Oviasu E
    West Afr J Med; 2013; 32(1):19-25. PubMed ID: 23613290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creatinine increases after intravenous contrast administration: incidence and impact.
    Li J; Solomon RJ
    Invest Radiol; 2010 Aug; 45(8):471-6. PubMed ID: 20498612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the delay in thrombolysis: is it necessary to await the results of renal function tests before computed tomography perfusion and angiography in patients with code stroke?
    Mehdiratta M; Schlaug G; Kumar S; Caplan LR; Selim M
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):273-5. PubMed ID: 18755406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contrast-media-induced nephrotoxicity].
    Adolph E; Chatterjee T; Ince H; Eckard H; Rehders T; Kische S; Drawert S; Petzsch M; Nienaber CA
    Dtsch Med Wochenschr; 2005 Oct; 130(42):2391-6. PubMed ID: 16235148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to avoid CIN: guidelines from the European Society of Urogenital Radiology.
    Thomsen HS
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i18-22. PubMed ID: 15705944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast medium-induced nephropathy: strategies for prevention.
    Massicotte A
    Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
    Pannu N; Tonelli M
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):285-90. PubMed ID: 16609296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast medium administration in the elderly patient: is advancing age an independent risk factor for contrast nephropathy after angiographic procedures?
    Detrenis S; Meschi M; Bertolini L; Savazzi G
    J Vasc Interv Radiol; 2007 Feb; 18(2):177-85; quiz 185. PubMed ID: 17327549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines].
    Meschi M; Detrenis S; Savazzi G
    Recenti Prog Med; 2008 Mar; 99(3):155-62. PubMed ID: 18488528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guideline 'Precautionary measures for contrast media containing iodine'].
    van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When to test renal function to disclose contrast-induced nephropathy.
    Aguiar-Souto P; Valero-González S
    Am J Cardiol; 2008 Aug; 102(3):371. PubMed ID: 18638608
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
    Morikawa S; Sone T; Tsuboi H; Mukawa H; Morishima I; Uesugi M; Morita Y; Numaguchi Y; Okumura K; Murohara T
    J Am Coll Cardiol; 2009 Mar; 53(12):1040-6. PubMed ID: 19298916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.
    Rao QA; Newhouse JH
    Radiology; 2006 May; 239(2):392-7. PubMed ID: 16543592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.